Abstract
Auxiliary liver transplantation (ALT), retaining in place the liver of the recipient, has been proposed as an alternative to liver replacement in patients with fulminant hepatic failure (FHF). Hepatobiliary scintigraphy (HS) has proved a unique tool for the separate assessment of graft and native liver function. Forty-eight HS scans were performed, following the injection of technetium-99m trimethyl-bromo-imino-diacetic acid, in six patients who underwent ALT for FHF. Quantitative parameters were derived from the time-activity curves of both the graft and the native liver. The function of the graft remained normal as long as the patients remained under immunosuppressive therapy (IST). The function of the native liver was almost completely absent in the 1st month in five patients, but it improved gradually in four of them. IST was then decreased in four patients and finally withdrawn in three. Spontaneous graft atrophy occurred in two patients and the graft was removed in two. All of the patients in whom IST was reduced had a normal global hepatic function and selective uptake (RU) >30% at that time. In ALT patients with FHF, HS can distinguish non-invasively the functional performance of both the donor and the recipient liver and its evolution with time.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gohda E, Yamasaki T, Tsubouchi H, Kurobe M, Sakiyama O, Aoki H, Niidani N, Shin S, Hayashi K, Hashimoto S, Daikuhara Y, Yamamoto I. Biological and immunological properties of human hepatocyte growth factor from plasma of patients with fulminant hepatic failure.Biochim Biophys Acta 1990; 21: 1053.
Karvountzis GG, Redeker AG, Peters RL. Long term follow-up studies of patients surviving viral hepatitis.Gastroenterology 1974; 67: 870.
Bernuau J. Fulminant and subfulminant hepatitis: liver regeneration and prognosis. In: Bernuau D, Feldmann G.Liver regeneration. Paris: John Libbey Eurotext; 1992: 147–157.
Terpstra OT, Schalm SW, Weimar W, Willemse PJA, Baumgartner D, Groenland THN, Ten Kate FWJ, Porte RJ, De Rave S, Reuvers CB. Auxiliary partial liver transplantation for endstage chronic liver disease.N Engl J Med 1988; 319: 1507–1511.
Metselaar HJ, Hesselink EJ, De Rave S, ten Kate FS, Lameris JS, Groenland TH, Reuvers CB, Weimar W, Terpstra OT, Schalm SW. Recovery of failing liver after auxiliary heterotopic transplantation.Lancet 1990; 335: 1156–1157.
Gubernatis G, Pichlmayr R, Kemnitz J, Gratz K. Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: first cases report.World J Surg 1991; 15: 660–666.
Belghiti J, Zinzindohoue F, Durand F, Noun R, Sauvanet A, Bernuau J. Auxiliary liver transplantation for fulminant liver failure: limits of an attractive concept.Hepatology 1995; 22: 153a.
Boudjema K, Cherqui D, Jaeck D, et al. Auxiliary liver transplantation for fulminant and subfulminant hepatic failure.Transplantation 1995; 59: 218–223.
Moritz MJ, Jarrell BE, Munoz SJ, Maddrey WC. Regeneration of the native liver after heterotopic liver transplantation for fulminant hepatic failure.Transplantation 1992; 55: 952–954.
Willemse PJA, Ausema L, Terpstra OT, Krenning EP, Ten Kate FWJ, Schalm SW. Graft regeneration and host liver atrophy after auxiliary heterotopic liver transplantation for chronic liver failure.Hepatology 1992; 15: 54–57.
van Hoek B, Ringers J, Kroes AC, van Krieken JH, van Schelven WD, Masclee AA, van Krikken-Hogenberk LG, Haak HR, Lamers CB, Terpstra OT. Temporary heterotopic auxiliary liver transplantation for fulminant hepatitis B.J Hepatol 1995; 23: 109–118.
Johansson L, Mattsson S, Nosslin B, Leide-Svegborn S. Effective dose from radiopharmaceuticals.Eur J Nucl Med 1992; 11: 934–939.
Provoost AP, Madern GC, Sinaasappel M, Molenaar JC, Terpstra OT. Sequential changes in relative liver function assessed by99mTc-HIDA scintigraphy after auxiliary heterotopic liver transplantation in dogs.J Pediatr Surg 1991; 26: 1087–1090.
Engeler CM, Kuni CC, Nakhleh R, Engeler CE, duCret RP, Boudreau RJ. Liver transplant rejection and cholestasis: comparison of technetium 99m-diisopropyl iminodiacetic acid hepatobiliary imaging with liver biopsy.Eur J Nucl Med 1992; 19: 865–870.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Buyck, D., Bonnin, F., Bernuau, J. et al. Auxiliary liver transplantation in patients with fulminant hepatic failure: Hepatobiliary scintigraphic follow-up. Eur J Nucl Med 24, 138–142 (1997). https://doi.org/10.1007/BF02439545
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02439545